Annals On Call Podcast
Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.
Latest Episode
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes (19.08.2025)
Previous Episodes
- Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide 05.08.2025
- Diagnosing Primary Aldosteronism 15.07.2025
- Virtual Urgent Care: Artificial Intelligence Versus Physicians 01.07.2025
- Pseudogout Syndrome 17.06.2025
- Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in the Absence of Diabetes 03.06.2025
- Advanced Practice Clinicians Cannot Replace Primary Care Physicians 20.05.2025
- Chronic Kidney Disease: What Generalists Need to Know 06.05.2025
- Health Expenditures of Patients With Diabetes After Bariatric Surgery 15.04.2025
- Is Adherence to (SEP-1) Linked to Mortality Reduction for Patients with Sepsis? 01.04.2025
- Metabolic Dysfunction-Associated Steatotic Liver Disease 17.03.2025
- Lack of Control and Physician Burnout 03.03.2025
- Teaching Diagnostic Reasoning 17.02.2025
- Evidence-Based Treatment of Low Back Pain 03.02.2025
- Diagnostic Reasoning Part 2 20.01.2025
- Diagnostic Reasoning Part 1 07.01.2025
- Transfusion Thresholds in Myocardial Infarction 17.12.2024
- Lifestyle Recommendations: Can They Really Improve Public Health? 03.12.2024
- Renin Angiotensin System Blockade in Persons with Advanced Chronic Kidney Disease 18.11.2024
- Kratom: A Substance Physicians Should Be Aware Of 04.11.2024
- Reviving Humility in Physicians 15.10.2024
